Recent News

  • 09:12 PM Dec 27th
    NEJM Gender diversity in academic medicine - Among medical students who graduated between 1979 and 2013, women who went into academic medicine were less likely than men to advance into upper faculty ranks. These gaps did not narrow during the 35-year time frame of this study
  • 06:12 PM Dec 27th
    NEJM: beneficial hospital outcomes - lower mortality (adj RR 0.84, 95% CI 0.78-0.90; p<0.001), lower  incidence ICU admission, and shorter hospital LOS - associated with staggered deployment of automated predictive model that identifies patients at higher risk of clinical deterioration and alerts staff.
  • 11:12 PM Dec 24th
    NeoSupra trial - neonates with asphyxia requiring PPV, LMA was safely used by midwives but not superior to FMV with respect to early neonatal death and moderate-to-severe HIE (27.4% LMA vs 24.4% FMV, adj RR 1.16, 95% CI 0.90 to 1.51)
  • 11:12 PM Dec 24th
    NEJM PlasmAr Trial: Convalescent plasma administration resulted no difference  distribution clinical outcomes (OR, 0.83 (95% CI, 0.52 to 1.35; P=0.46) in adults with severe SARS-CoV-2 pneumonia compared to placebo
  • 08:12 PM Dec 24th
    NEJM: WHO Solidarity trial reports no reduction in main outcomes of mortality, ventilation, hospitalization duration with any trial drugs (remdesivir, hydroxychloroquine, lopinavir, and interferon) either overall or in any particular subgroup, or after meta-analysis of available trials. Importantly, this casts doubts about the effectiveness of remdesivir

Social Media